We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App





At Least One Effective COVID-19 Vaccine to Be Available by 2021, But Only in Limited Quantities, Says WHO

By HospiMedica International staff writers
Posted on 16 Oct 2020
Print article
Illustration
Illustration
There would be at least one safe and effective COVID-19 vaccine by 2021, although it will be available in “limited quantities” which may require priority to be given to vulnerable people and result in a delay in the immunization of healthy, young people until 2022.

The World Health Organization’s (WHO Geneva, Switzerland) chief scientist, Dr. Soumya Swaminathan, has warned that young and healthy people should be prepared to wait for immunization for well over a year. Speaking at a WHO social media event, Dr. Swaminathan said that despite the global efforts for developing a COVID-19 vaccine and several candidates undergoing clinical trials, speedy and mass inoculation was highly unlikely. Health-care workers and others on the front lines would be the first ones to receive a COVID-19 vaccine, followed by the elderly or sick. The WHO would work along with governments and international organizations to ensure that the people facing the highest risk receive priority for the vaccine. This means that the remaining young population who are in sound health would have to wait longer to be vaccinated.

“Most people agree, it’s starting with health care workers, and front-line workers, but even there, you need to define which of them are at highest risk, and then the elderly, and so on,” said Dr. Swaminathan. “There will be a lot of guidance coming out, but I think an average person, a healthy young person might have to wait until 2022 to get a vaccine.”

Separately, Robin Nandy, the chief of immunization at UNICEF, said in an interview that COVID-19 vaccines would be initially available only in small quantities that would be insufficient to vaccinate the world’s entire population.

“Vaccines are going to be available in the initial years in too small quantities to vaccinate the seven billion people we have across the globe today,” Robin Nandy, the chief of immunization at UNICEF, said in an interview. “Vaccines will arrive in dribs and drabs.”

People providing essential services such as health care and education should be among the first to be vaccinated, he said. “We have to live with the pandemic for a while, so we need these systems to continue."

Related Links:
World Health Organization

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
X-Ray QA Meter
Piranha CT

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.